ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit
Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR). Class Period: May 17, 2022 – July 19, 2024Lead Plaintiff Deadline: November 12, 2024 If you wish to serve as lead plaintiff of […]